Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | -2.52% | -9.15% | -27.63% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.63% | 82M | |
+5.41% | 111B | |
+12.23% | 105B | |
-12.59% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.87% | 16.96B | |
+5.15% | 13.7B | |
+37.45% | 12.45B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Goldman Sachs Cuts Price Target on BioXcel Therapeutics to $4 From $12, Maintains Neutral Rating